Exagen Inc.
XGN
$8.63
$0.232.74%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 10.99% | 13.50% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 10.99% | 13.50% | |||
| Cost of Revenue | 6.78% | 23.12% | |||
| Gross Profit | 13.94% | 7.62% | |||
| SG&A Expenses | 3.02% | 9.80% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.14% | 10.71% | |||
| Operating Income | 21.84% | 0.53% | |||
| Income Before Tax | -17.32% | -0.08% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -18.31% | 0.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -18.31% | 0.24% | |||
| EBIT | 21.84% | 0.53% | |||
| EBITDA | 26.02% | 1.45% | |||
| EPS Basic | -4.10% | 0.93% | |||
| Normalized Basic EPS | 13.92% | 0.63% | |||
| EPS Diluted | -4.10% | 0.93% | |||
| Normalized Diluted EPS | 13.92% | 0.63% | |||
| Average Basic Shares Outstanding | 13.62% | 0.70% | |||
| Average Diluted Shares Outstanding | 13.62% | 0.70% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||